204 related articles for article (PubMed ID: 7891119)
1. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.
Flynn DD; Ferrari-DiLeo G; Mash DC; Levey AI
J Neurochem; 1995 Apr; 64(4):1888-91. PubMed ID: 7891119
[TBL] [Abstract][Full Text] [Related]
2. Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies.
Flynn DD; Ferrari-DiLeo G; Levey AI; Mash DC
Life Sci; 1995; 56(11-12):869-76. PubMed ID: 10188787
[TBL] [Abstract][Full Text] [Related]
3. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
Shiozaki K; Iseki E; Uchiyama H; Watanabe Y; Haga T; Kameyama K; Ikeda T; Yamamoto T; Kosaka K
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):209-13. PubMed ID: 10406992
[TBL] [Abstract][Full Text] [Related]
4. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia.
Vanderheyden P; Ebinger G; Dierckx R; Vauquelin G
J Neurol Sci; 1987 Dec; 82(1-3):257-69. PubMed ID: 3440867
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor subtypes are differentially distributed in the rat cochlea.
Khan KM; Drescher MJ; Hatfield JS; Khan AM; Drescher DG
Neuroscience; 2002; 111(2):291-302. PubMed ID: 11983315
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease.
Rodríguez-Puertas R; Pascual J; Vilaró T; Pazos A
Synapse; 1997 Aug; 26(4):341-50. PubMed ID: 9215593
[TBL] [Abstract][Full Text] [Related]
8. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
Yasuda RP; Ciesla W; Flores LR; Wall SJ; Li M; Satkus SA; Weisstein JS; Spagnola BV; Wolfe BB
Mol Pharmacol; 1993 Feb; 43(2):149-57. PubMed ID: 8429821
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction?
Tayebati SK; Amenta F; Amici S; El-Assouad D; Gallai V; Ricci A; Parnetti L
J Neuroimmunol; 2001 Dec; 121(1-2):126-31. PubMed ID: 11730949
[TBL] [Abstract][Full Text] [Related]
10. Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study.
Shiozaki K; Iseki E; Hino H; Kosaka K
J Neurol Sci; 2001 Dec; 193(1):23-8. PubMed ID: 11718746
[TBL] [Abstract][Full Text] [Related]
11. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Flynn DD; Weinstein DA; Mash DC
Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
[TBL] [Abstract][Full Text] [Related]
12. Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.
Scarr E; McLean C; Dean B
J Neural Transm (Vienna); 2017 Mar; 124(3):273-284. PubMed ID: 27688247
[TBL] [Abstract][Full Text] [Related]
13. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
[TBL] [Abstract][Full Text] [Related]
14. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease.
Quirion R; Aubert I; Lapchak PA; Schaum RP; Teolis S; Gauthier S; Araujo DM
Trends Pharmacol Sci; 1989 Dec; Suppl():80-4. PubMed ID: 2694529
[TBL] [Abstract][Full Text] [Related]
16. Characterization of muscarinic cholinergic receptor subtypes in rat prostate.
Pontari MA; Luthin GR; Braverman AS; Ruggieri MR
J Recept Signal Transduct Res; 1998; 18(2-3):151-66. PubMed ID: 9651883
[TBL] [Abstract][Full Text] [Related]
17. Towards a high-affinity allosteric enhancer at muscarinic M1 receptors.
Lazareno S; Popham A; Birdsall NJ
J Mol Neurosci; 2002; 19(1-2):123-7. PubMed ID: 12212769
[TBL] [Abstract][Full Text] [Related]
18. Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues.
Dörje F; Levey AI; Brann MR
Mol Pharmacol; 1991 Oct; 40(4):459-62. PubMed ID: 1921982
[TBL] [Abstract][Full Text] [Related]
19. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
Rinne JO; Lönnberg P; Marjamäki P; Rinne UK
Brain Res; 1989 Apr; 483(2):402-6. PubMed ID: 2706531
[TBL] [Abstract][Full Text] [Related]
20. Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study.
Probst A; Cortés R; Ulrich J; Palacios JM
Brain Res; 1988 May; 450(1-2):190-201. PubMed ID: 3401711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
